ACP
QGENF

Arrowgrass Capital Partners’s QIAGEN NV QGENF Stock Holding History

Arrowgrass Capital Partners’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-36,000
Closed -$995K – 32
2015
Q4 		$995K Buy
+36,000
New +$995K 0.26% 19

Other funds holding QGENF

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowgrass Capital Partners's QGENF Position: Q1 2016 in Review

Arrowgrass Capital Partners sold out of QIAGEN NV (QGENF) in Q1 2016, closing a stake of 36,000 shares — an estimated $995K sold.

Arrowgrass Capital Partners first reported a position in QGENF in Q4 2015 and held it in 1 quarter. The position peaked at $995K in Q4 2015. 201 funds tracked by Wall St. Rank hold QGENF as of Q1 2016.

  • Arrowgrass Capital Partners reported no remaining QIAGEN NV position as of Q1 2016 after selling out during the quarter.
  • Arrowgrass Capital Partners sold 36,000 QIAGEN NV shares in Q1 2016, an estimated $995K.
  • Arrowgrass Capital Partners first reported a position in QIAGEN NV in Q4 2015 and held it in 1 quarter.
  • Arrowgrass Capital Partners's QIAGEN NV position peaked at $995K in Q4 2015.
  • 201 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2016.

Based on Arrowgrass Capital Partners's 13F filing for Q1 2016, filed 16 May 2016.